FP-7832

N/A

Report date: 2024/12/04 16:49:16

Base Information

Drug NameFP-7832
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitorsAcetylcholine receptor; alpha1/beta1/delta/gamma agonists
TargetsAcetylcholinesteraseAcetylcholine receptor; alpha1/beta1/delta/gamma
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesFaust Pharmaceuticals (Switzerland) SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFaust Pharmaceuticals (Switzerland) SA
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A